Glucotrack Inc. (GCTK) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Glucotrack Inc. (GCTK:NASDAQ), powered by AI.

Current Price
$0.40
Sector
Healthcare
What is the Glucotrack Inc. stock price forecast?

Glucotrack Inc. is currently trading at $0.40. View real-time AI analysis on Alpha Lenz.

What is Glucotrack Inc. insider trading activity?

View the latest insider trading data for Glucotrack Inc. on Alpha Lenz.

What is Glucotrack Inc.'s P/E ratio?

View Glucotrack Inc.'s valuation metrics on Alpha Lenz.

Glucotrack Inc.

NASDAQ · GCTK
$0.40-0.01(-2.22%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Glucotrack Inc.'s future dividend policy...
Alpha Chat Insight

Glucotrack Inc.'s ROE is 381.2%. Explore profitability and growth together.

Ask for details

Company Overview

Glucotrack Inc. is a company dedicated to developing non-invasive glucose monitoring technology. The core purpose of the company is to provide an alternative method for individuals with diabetes to track their blood glucose levels without the need for frequent finger-prick tests. This innovation primarily serves the healthcare and biotechnology sectors, offering a user-friendly solution that aims to improve patient comfort and compliance. The Glucotrack device is designed to measure glucose levels using several physiological parameters detected via an ear clip, conveying real-time data that can be crucial for metabolic management. Its focus on non-invasive technology positions it as a potential game-changer in the realm of diabetic care, especially considering the global prevalence of diabetes. In the broader market context, Glucotrack Inc. represents a significant development within the medtech industry, with its efforts reflecting an ongoing trend towards more patient-centered, convenient healthcare solutions. Its contribution lies not only in its innovative approach but also in its potential to reduce the physical and psychological barriers associated with traditional glucose monitoring methods.

CEODr. Paul V. Goode Ph.D.
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees11

Company Statistics

FY 2025

Profile

N/AMarket Cap
$0.00Revenue
0.00Shares Out
11Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-281.60%ROA
381.20%ROE
-233.70%ROIC

Financial Health

$7.38MCash & Cash Equivalents
$-2.37MNet Debt
177.16%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Glucotrack Inc. (ticker: GCTK) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 11 employees.

The current price is $0.397 with a P/E ratio of -x and P/B of -x.

ROE is 381.20%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Glucotrack Inc. (GCTK) Stock Forecast 2026 $0.40 — Price, Financials & Analyst Targets | Alpha Lenz